Its only a small group of 9 MS patients with aggressive MS followed for up to 24 month. But a 39% average improvemt in EDSS sounds promising.
I posted the same study in the HDC forum because it seems to fit in both.
If I should avoid "doubleposting" of that kind in the future please let me know which forum I should prefer in a similar situation.
Treatment: Gilenya since 01/2011, CCSVI both IJV ballooned 09/2010, Tysabri stopped after 24 Infusions and positive JCV antibody test, after LDN, ABX Wheldon Regime for 1 year.